Insmed, Merus announce public offerings; AI startup raises $13M seed round

Plus, news about AEON Biopharma, Bio-Thera and STADA:

Insmed to raise $500M in public offering: The startup launched the offering after …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Cytisinicline could offer adult cigarette smokers a potential new treatment option

The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and

July 11, 2023

Pharmalittle: We’re reading about FTC probing Teva patents, a Moderna flu vaccine contract, and more

Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, given the clear

July 2, 2024

Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD – Psychedelic Alpha

Company also announces that the IMPACT-1 clinical trial is underway with open-label results expected in the coming months NEW YORK, Sept. 21, 2023 /PRNewswire/ — Transcend

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.